GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the dual GIP/GLP-1 agonist tirzepatide carry the clinical evidence: STEP for semaglutide ( The New England Journal of Medicine , 2021), SURMOUNT for tirzepatide (NEJM, 2022), and SURMOUNT-OSA for tirzepatide in obstructive sleep apnea (NEJM, 2024)
GLP-1 drugs are not the enemy
Lower levels of muscle mass also can lead to lower energy levels
PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) across all dosing levelsyour dose may increase as your body adapts, but your price remains consistent, allowing you to focus on managing side effects without cost worries
your quality of life is good
Prophylactic neck dissection (ie, elective neck dissection) is not advocated as a treatment for oral melanoma